Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Read More…
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Phone717-761-2633
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$21.64 billion
Profitability
Miscellaneous
Employees51,000
Next Earnings Date4/9/2020 (Estimated)
OptionableOptionable
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
When did Rite Aid's stock split? How did Rite Aid's stock split work?
Rite Aid shares reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.
How were Rite Aid's earnings last quarter?
Rite Aid Co. (NYSE:RAD) announced its quarterly earnings data on Thursday, December, 19th. The company reported $0.54 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.45. The firm had revenue of $5.46 billion for the quarter, compared to the consensus estimate of $5.42 billion. Rite Aid had a negative net margin of 1.86% and a positive return on equity of 1.40%. Rite Aid's quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.01 EPS. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid issued an update on its FY20 earnings guidance on Thursday, December, 19th. The company provided earnings per share guidance of $0.13-0.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.18. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $21.64 billion.
What price target have analysts set for RAD?
3 analysts have issued 12-month price targets for Rite Aid's stock. Their forecasts range from $12.00 to $12.00. On average, they expect Rite Aid's stock price to reach $12.00 in the next twelve months. This suggests that the stock has a possible downside of 4.8%. View Analyst Price Targets for Rite Aid.
What is the consensus analysts' recommendation for Rite Aid?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 sell ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rite Aid.
Has Rite Aid been receiving favorable news coverage?
News stories about RAD stock have been trending extremely negative on Saturday, InfoTrie reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Rite Aid earned a media sentiment score of -5.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Rite Aid.
Who are some of Rite Aid's key competitors?
What other stocks do shareholders of Rite Aid own?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, CEO & Director (Age 56)
- Mr. Kermit Ray Crawford, Pres & COO (Age 60)
- Mr. Bryan B. Everett, Chief Operating Officer (Age 46)
- Mr. Darren Wayne Karst, Exec. Officer (Age 59)
- Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy & Retail Operations (Age 49)
Who are Rite Aid's major shareholders?
Rite Aid's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Investors Asset Management of Georgia Inc. GA ADV (0.04%), CenterStar Asset Management LLC (0.01%), Johanson Financial Advisors Inc. (0.01%) and Allred Capital Management LLC (0.01%). View Institutional Ownership Trends for Rite Aid.
Which institutional investors are selling Rite Aid stock?
Which institutional investors are buying Rite Aid stock?
RAD stock was bought by a variety of institutional investors in the last quarter, including CenterStar Asset Management LLC, Johanson Financial Advisors Inc. and Allred Capital Management LLC. View Insider Buying and Selling for Rite Aid.
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $12.60.
How big of a company is Rite Aid?
What is Rite Aid's official website?
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (NYSE RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
